Advertisement

Topics

Mentor Capital Acquires $1.0 Million of GW Pharmaceuticals, Plc

11:17 EST 3 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Debt-free Cannabis M&A Leader Deploys Part of $2.5 Million in New Cash Mentor Capital, Inc. (OTCQB: MNTR) announced it has taken a $1.0 million position in the stock of GW Pharmaceuticals, Plc (NASDAQ: GWPH), a Un...

Other Sources for this Article

Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788 - 4700

NEXT ARTICLE

More From BioPortfolio on "Mentor Capital Acquires $1.0 Million of GW Pharmaceuticals, Plc"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...